Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

被引:2
|
作者
Ilona Joniec-Maciejak
Adriana Wawer
Danuta Turzyńska
Alicja Sobolewska
Piotr Maciejak
Janusz Szyndler
Dagmara Mirowska-Guzel
Adam Płaźnik
机构
[1] Medical University of Warsaw,Department of Experimental and Clinical Pharmacology
[2] Centre for Preclinical Research and Technology (CePT),Department of Neurochemistry
[3] Institute of Psychiatry and Neurology,undefined
来源
Pharmacological Reports | 2018年 / 70卷
关键词
Parkinson’s disease; Octanoic acid; MPTP; PGC-1α; PEPCK;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:988 / 992
页数:4
相关论文
共 50 条
  • [31] Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease
    Perez-H, Jesus
    Carrillo-S, Carlos
    Garcia, Esperanza
    Ruiz-Mar, Gabriela
    Perez-Tamayo, Ruy
    Chayarria, Anahi
    TOXICOLOGY, 2014, 319 : 38 - 43
  • [32] Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease
    Chen, YiMei
    Zhang, Yanfang
    Li, Lin
    Hoelscher, Christian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 768 : 21 - 27
  • [33] Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease
    Schmidt, N
    Ferger, B
    SYNAPSE, 2001, 40 (01) : 47 - 54
  • [34] Regulation of DNA repair in the MPTP mouse model of Parkinson's disease
    Sava, V
    Velazquez, A
    Song, S
    Sanchez-Ramos, J
    MOVEMENT DISORDERS, 2005, 20 (09) : 1248 - 1248
  • [35] Behavioral characterization in MPTP/p mouse model of Parkinson's disease
    Wada, Mai
    Ang, Mary Jasmin
    Weerasinghe-Mudiyanselage, Poornima D. E.
    Kim, Sung-Ho
    Kim, Jong-Choon
    Shin, Taekyun
    Moon, Changjong
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2021, 20 (02) : 307 - 320
  • [36] Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
    Cornelius J. H. M. Klemann
    Gerard J. M. Martens
    Geert Poelmans
    Jasper E. Visser
    Molecular Neurobiology, 2016, 53 : 1625 - 1636
  • [37] Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease
    Zhang, Lingling
    Huang, LinHong
    Chen, Liangwei
    Hao, Dingjun
    Chen, Jianzong
    TOXICOLOGY LETTERS, 2013, 222 (02) : 155 - 163
  • [38] Transiently impaired neurogenesis in MPTP mouse model of Parkinson's disease
    He, Xi Jun
    Nakayama, Hiroyuki
    NEUROTOXICOLOGY, 2015, 50 : 46 - 55
  • [39] Validity of the MPTP-Treated Mouse as a Model for Parkinson's Disease
    Klemann, Cornelius J. H. M.
    Martens, Gerard J. M.
    Poelmans, Geert
    Visser, Jasper E.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (03) : 1625 - 1636
  • [40] Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease
    Geng, Xingchao
    Tian, Xuefei
    Tu, Pengfei
    Pu, Xiaoping
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 564 (1-3) : 66 - 74